Efficacy of Percutaneous Mitral Balloon Valvuloplasty With the Inoue Balloon

RICK A. NISHIMURA, David Holmes, GUY S. REEDER

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Percutaneous mitral balloon valvuloplasty has become an accepted technique for use in selected patients with severe, symptomatic mitral stenosis. Recently, a new balloon catheter with an “hourglass” shape and specially designed guidewires and dilators has become available (Inoue balloon). The design of this balloon provides ease of manipulation and self-stabilization across the mitral valve during inflation. These features should decrease the incidence of complications associated with the procedure. Preliminary results in 12 consecutive patients who underwent percutaneous mitral balloon valvuloplasty with the Inoue balloon are presented. The mitral valve area increased from 0.92 ± 0.21 cm2 before the procedure to 1.75 ± 0.40 cm2 after the procedure. No complications occurred from the procedure, including no increase in severity of mitral regurgitation or creation of an atrial septal defect. Further follow-up is necessary to determine the long-term efficacy with this new balloon. Nonetheless, the preliminary results are encouraging.

Original languageEnglish (US)
Pages (from-to)276-282
Number of pages7
JournalMayo Clinic proceedings
Volume66
Issue number3
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Balloon Valvuloplasty
Mitral Valve
Atrial Heart Septal Defects
Mitral Valve Stenosis
Economic Inflation
Mitral Valve Insufficiency
Catheters
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Efficacy of Percutaneous Mitral Balloon Valvuloplasty With the Inoue Balloon. / NISHIMURA, RICK A.; Holmes, David; REEDER, GUY S.

In: Mayo Clinic proceedings, Vol. 66, No. 3, 01.01.1991, p. 276-282.

Research output: Contribution to journalArticle

NISHIMURA, RICK A. ; Holmes, David ; REEDER, GUY S. / Efficacy of Percutaneous Mitral Balloon Valvuloplasty With the Inoue Balloon. In: Mayo Clinic proceedings. 1991 ; Vol. 66, No. 3. pp. 276-282.
@article{e437bcddde2e4893957cea1a4977ff2f,
title = "Efficacy of Percutaneous Mitral Balloon Valvuloplasty With the Inoue Balloon",
abstract = "Percutaneous mitral balloon valvuloplasty has become an accepted technique for use in selected patients with severe, symptomatic mitral stenosis. Recently, a new balloon catheter with an “hourglass” shape and specially designed guidewires and dilators has become available (Inoue balloon). The design of this balloon provides ease of manipulation and self-stabilization across the mitral valve during inflation. These features should decrease the incidence of complications associated with the procedure. Preliminary results in 12 consecutive patients who underwent percutaneous mitral balloon valvuloplasty with the Inoue balloon are presented. The mitral valve area increased from 0.92 ± 0.21 cm2 before the procedure to 1.75 ± 0.40 cm2 after the procedure. No complications occurred from the procedure, including no increase in severity of mitral regurgitation or creation of an atrial septal defect. Further follow-up is necessary to determine the long-term efficacy with this new balloon. Nonetheless, the preliminary results are encouraging.",
author = "NISHIMURA, {RICK A.} and David Holmes and REEDER, {GUY S.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/S0025-6196(12)61009-X",
language = "English (US)",
volume = "66",
pages = "276--282",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "3",

}

TY - JOUR

T1 - Efficacy of Percutaneous Mitral Balloon Valvuloplasty With the Inoue Balloon

AU - NISHIMURA, RICK A.

AU - Holmes, David

AU - REEDER, GUY S.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Percutaneous mitral balloon valvuloplasty has become an accepted technique for use in selected patients with severe, symptomatic mitral stenosis. Recently, a new balloon catheter with an “hourglass” shape and specially designed guidewires and dilators has become available (Inoue balloon). The design of this balloon provides ease of manipulation and self-stabilization across the mitral valve during inflation. These features should decrease the incidence of complications associated with the procedure. Preliminary results in 12 consecutive patients who underwent percutaneous mitral balloon valvuloplasty with the Inoue balloon are presented. The mitral valve area increased from 0.92 ± 0.21 cm2 before the procedure to 1.75 ± 0.40 cm2 after the procedure. No complications occurred from the procedure, including no increase in severity of mitral regurgitation or creation of an atrial septal defect. Further follow-up is necessary to determine the long-term efficacy with this new balloon. Nonetheless, the preliminary results are encouraging.

AB - Percutaneous mitral balloon valvuloplasty has become an accepted technique for use in selected patients with severe, symptomatic mitral stenosis. Recently, a new balloon catheter with an “hourglass” shape and specially designed guidewires and dilators has become available (Inoue balloon). The design of this balloon provides ease of manipulation and self-stabilization across the mitral valve during inflation. These features should decrease the incidence of complications associated with the procedure. Preliminary results in 12 consecutive patients who underwent percutaneous mitral balloon valvuloplasty with the Inoue balloon are presented. The mitral valve area increased from 0.92 ± 0.21 cm2 before the procedure to 1.75 ± 0.40 cm2 after the procedure. No complications occurred from the procedure, including no increase in severity of mitral regurgitation or creation of an atrial septal defect. Further follow-up is necessary to determine the long-term efficacy with this new balloon. Nonetheless, the preliminary results are encouraging.

UR - http://www.scopus.com/inward/record.url?scp=0025907650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025907650&partnerID=8YFLogxK

U2 - 10.1016/S0025-6196(12)61009-X

DO - 10.1016/S0025-6196(12)61009-X

M3 - Article

C2 - 2002686

AN - SCOPUS:0025907650

VL - 66

SP - 276

EP - 282

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 3

ER -